Search results
Found 2883 matches for
The University of Oxford, together with three partner sites in London, Southampton and Bristol, is to launch the first study to assess the safety and immune responses in children and young adults of the ChAdOx1 nCoV-19 coronavirus vaccine.
OVG Alumni
Browse the OVG Alumni, including those who have undertaken a PhD/DPhil, MSc or MD (a graduate degree in the UK for medical graduates) at OVG since 2001, with date of graduation and where available information on their current or most recent/notable role.
Research
The Oxford Vaccine Group conducts laboratory and clinical research in many different areas related to infectious diseases and vaccination in childhood as well as adulthood. Below you can browse all the different areas we investigate.
Study & Train @ OVG
We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.
Our Team
The Oxford Vaccine Group is led by its director Professor Sir Andrew Pollard. Browse the full list of members of our team below.